Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial

Biostar Stem Cell Research Institute (R-Bio)

Status and phase: Active, not recruiting; Phase 3

Conditions: Knee Osteoarthritis

Treatments: Biological: JOINTSTEM

Study type: Interventional

Funder types: Industry

Identifiers

NCT04427930

BSR-CTph3-JS1_FU

Details and patient eligibility

About

The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.

Enrollment: 129 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants of Jointstem Phase 3 Clinical Trial
• Participates who signed informed consent document of this study

Exclusion criteria

• No applicable

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

129 participants in 1 patient group

JOINTSTEM

Experimental group

Description:

Long Term Follow-up after Jointstem Transplantation

Treatment:

Biological: JOINTSTEM